J. C. Wiley, L. A. Wailes, R. L. Idzerda, and G. S. Mcknight, Role of regulatory 622 subunits and protein kinase inhibitor (PKI) in determining nuclear localization and 623 activity of the catalytic subunit of protein kinase A, J Biol Chem, vol.274, pp.6381-6388, 1999.

A. Horvath, S. Boikos, C. Giatzakis, A. Robinson-white, L. Groussin et al., , p.625

E. Stein, E. Levine, G. Delimpasi, H. P. Hsiao, M. Keil et al., , p.626

L. Libe, R. Fratticci, A. Kirschner, L. S. Cramer, K. Gaillard et al., , p.627

J. A. Carney, J. Bertherat, I. Bossis, and C. A. Stratakis, A genome-wide scan 628 identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in 629 individuals with adrenocortical hyperplasia, Nat Genet, vol.38, pp.794-800, 2006.

A. Horvath, C. Giatzakis, K. Tsang, E. Greene, P. Osorio et al., , p.631

Y. Patronas, A. Robinson-white, E. Remmers, and J. Bertherat, , p.632

C. A. Stratakis, A cAMP-specific phosphodiesterase (PDE8B) that is mutated in 633 adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B 634 isoform in human adrenal cortex, Eur J Hum Genet, vol.16, pp.1245-53, 2008.

R. Philipova and M. Whitaker, MAP kinase activity increases during mitosis in 636 early sea urchin embryos, J Cell Sci, vol.111, pp.2497-505, 1998.

M. Bolte, P. Dieckhoff, C. Krause, G. H. Braus, and S. Irniger, Synergistic 638 inhibition of APC/C by glucose and activated Ras proteins can be mediated by each of 639 the Tpk1-3 proteins in Saccharomyces cerevisiae, Microbiology, vol.149, pp.1205-1221, 2003.

K. Kurokawa and J. Kato, Cyclic AMP delays G2 progression and prevents 641 efficient accumulation of cyclin B1 proteins in mouse macrophage cells, Cell Struct 642 Funct, vol.23, pp.357-65, 1998.

A. Yu, Z. Zhang, Q. Bi, B. Sun, W. Su et al., , p.644

B. Yu, Regulation of cAMP on the first mitotic cell cycle of mouse embryos, p.645, 2008.

, Mol Reprod Dev, vol.75, pp.489-95

D. J. Withers, Signalling pathways involved in the mitogenic effects of cAMP, p.647, 1997.

, Clin Sci (Lond), vol.92, pp.445-51

P. Vandame, C. Spriet, D. Trinel, A. Gelaude, K. Caillau et al., The spatio-temporal dynamics of PKA activity profile during 650 mitosis and its correlation to chromosome segregation, Cell Cycle, vol.13, pp.3232-3272, 2014.

T. Imaizumi-scherrer, D. M. Faust, S. Barradeau, R. Hellio, and M. C. Weiss, , 2001.

, Type I protein kinase a is localized to interphase microtubules and strongly associated 653 with the mitotic spindle, Exp Cell Res, vol.264, pp.250-65

Y. Nakajima, T. Okamura, K. Horiguchi, T. Gohko, T. Miyamoto et al., , p.655

A. Ozawa, S. Ishii, E. Yamada, K. Hashimoto, S. Okada et al., GNAS mutations in adrenal aldosterone-producing adenomas, p.657, 2016.

, Endocr J, vol.63, pp.199-204

O. Mete and K. Duan, The Many Faces of Primary Aldosteronism and Cushing 659 Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity, Front Med, vol.660, issue.5, p.54, 2018.

L. Drougat, H. Omeiri, L. Lefevre, and B. Ragazzon, Novel Insights into the 662 Genetics and Pathophysiology of Adrenocortical Tumors, Front Endocrinol, vol.663, issue.6, p.96, 2015.

K. Bathon, I. Weigand, J. T. Vanselow, C. L. Ronchi, D. G. Di et al., PRKACA mutations in adrenal Cushing can alter substrate specificity, Endocrine Abstracts, p.665, 2017.

M. Fassnacht and D. Calebiro, Alterations in Protein Kinase A Substrate 666 Specificity as a Potential Cause of Cushing Syndrome, Endocrinology, vol.160, pp.447-459, 2019.

J. Liu, X. D. Li, A. Ora, P. Heikkila, A. Vaheri et al., cAMP-668 dependent protein kinase activation inhibits proliferation and enhances apoptotic 669 effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells, J Mol 670 Endocrinol, vol.33, pp.511-533, 2004.

F. Tissier, C. Cavard, L. Groussin, K. Perlemoine, G. Fumey et al., , p.672

F. Rene-corail, E. Jullian, C. Gicquel, X. Bertagna, and M. C. Vacher-lavenu, , p.673

C. Bertherat and J. , Mutations of beta-catenin in adrenocortical tumors: 674 activation of the Wnt signaling pathway is a frequent event in both benign and 675 malignant adrenocortical tumors, Cancer Res, vol.65, pp.7622-7629, 2005.

B. Ragazzon, R. Libe, S. Gaujoux, G. Assie, A. Fratticci et al., , p.677

X. Bertagna, F. Tissier, A. De-reynies, and J. Bertherat, Transcriptome 678 analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive 679 adrenocortical cancers, Cancer Res, vol.70, pp.8276-81, 2010.

R. S. Gupte, P. Pozarowski, J. Grabarek, F. Traganos, Z. Darzynkiewicz et al., , p.681

M. Y. , RIalpha influences cellular proliferation in cancer cells by transporting 682 RFC40 into the nucleus, Cancer Biol Ther, vol.4, pp.429-466, 2005.

G. Pidoux and K. Tasken, Specificity and spatial dynamics of protein kinase A 684 signaling organized by A-kinase-anchoring proteins, J Mol Endocrinol, vol.44, pp.271-84, 2010.

M. E. Day, G. M. Gaietta, M. Sastri, A. Koller, M. R. Mackey et al., , p.686

G. A. Ellisman, M. H. Taylor, and S. S. , Isoform-specific targeting of PKA to 687 multivesicular bodies, J Cell Biol, vol.193, pp.347-63, 2011.

D. Chaturvedi, M. S. Cohen, J. Taunton, and T. B. Patel, The PKARIalpha 689 subunit of protein kinase A modulates the activation of p90RSK1 and its function, J 690 Biol Chem, vol.284, pp.23670-81, 2009.

D. Chaturvedi, H. M. Poppleton, T. Stringfield, A. Barbier, and T. B. Patel, , p.692, 2006.

, Subcellular localization and biological actions of activated RSK1 are determined by 693 its interactions with subunits of cyclic AMP-dependent protein kinase, Mol Cell Biol, vol.694, pp.4586-600